AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
four-year guidance for high single-digit revenue growth and low double-digit EPS at constant FX, but warned of Q4 headwinds in China and tougher year-ago comps from $800m of 2024 milestones. The company spotlighted a deep late-stage pipeline after 16 positive Phase 3 readouts in 2025 and expects multiple 2026 launches including baxdrostat (PDUFA in Q2), camizestrant and garadacimab , plus numerous pivotal readouts across oncology, CVRM and rare diseases next year. AstraZeneca plans higher R&D investment (targeting the upper end of the low-20% of revenue in 2026) to support 104 Phase 3 studies , is scaling AI initiatives (IDA, QCS) and acquiring Modela AI, and reiterated confidence in its risk-adjusted $80 billion 2030 ambition Interested in AstraZeneca PLC? Here are five stocks we like better. How Does D-Wave Stack Up Against Quantum Competitors? AstraZeneca (NASDAQ:AZN) used its presentation at the J.P. Morgan Healthcare Conference to highlight strong 2025 performance, a gr
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- What Makes AstraZeneca (AZN) a Strong Growing Company? [Yahoo! Finance]Yahoo! Finance
- Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
- JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition [Yahoo! Finance]Yahoo! Finance
- Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 1/8/26 - Form 6-K
- 1/2/26 - Form 6-K
- 12/22/25 - Form 6-K
- AZN's page on the SEC website